Cost-effectiveness analysis study of HPV testing as a primary cervical cancer screening in Thailand

Cost-effectiveness analysis study of HPV testing as a primary cervical cancer screening in Thailand

Objectives: The aim of this study is to compare the cost and benefit of four different cervical cancer screening strategies involving primary HPV 16/18 genotyping, hrHPV testing alone and cytology for detecting CIN2+. Methods: Economical analysis using Markov modeling approach to combine the epidemi...

Full description

Bibliographic Details
Main Authors:	Wichai Termrungruanglert, Nipon Khemapech, Tanitra Tantitamit, Suleeporn Sangrajrang, Piyalamporn Havanond, Piyawat Laowahutanont
Format:	Article
Language:	English
Published:	Elsevier 2017-11-01
Series:	Gynecologic Oncology Reports
Subjects:	Cervical cancer Screening Human papillomavirus testing Liquid based cytology Markov model Cost effectiveness analysis
Online Access:	http://www.sciencedirect.com/science/article/pii/S2352578917300991

Similar Items

Cost-Effectiveness of Primary HPV Screening Strategies and Triage With Cytology or Dual Stain for Cervical Cancer
by: Tanitra Tantitamit MD, et al.
Published: (2020-05-01)

Cervical Cancer Screening Programs in Europe: The Transition Towards HPV Vaccination and Population-Based HPV Testing
by: Andreas C. Chrysostomou, et al.
Published: (2018-12-01)

Clinical Performance of Human Papillomavirus (HPV) Testing versus Cytology for Cervical Cancer Screening: Results of a Large Danish Implementation Study
by: Thomsen LT, et al.
Published: (2020-02-01)

THE ROLE OF CYTOLOGICAL AND VIROLOGICAL STUDIES IN SECONDARY PREVENTION OF CERVICAL CANCER
by: E. V. Bahidze, et al.
Published: (2014-07-01)

A comparison of cotton and flocked swabs for vaginal self-sample collection
by: Viviano M, et al.
Published: (2018-05-01)

Real-world effectiveness of primary screening with high-risk human papillomavirus testing in the cervical cancer screening programme in China: a nationwide, population-based study
by: Yanxia Zhao, et al.
Published: (2021-07-01)

Prospects for controlling cervical cancer at the turn of the century
by: Franco Eduardo L, et al.
Published: (2003-01-01)

Analysis of the efficacy of liquid-based cytology combined with HPV genotypes in screening cervical lesions in women of different ages
by: Jin Jun, et al.
Published: (2020-06-01)

Сontroversial issues in cytological screening for cervical cancer (literature review)
by: V. I. Novik
Published: (2020-11-01)

Prior cervical cytology and high-risk HPV testing results for 311 patients with invasive cervical adenocarcinoma: a multicenter retrospective study from China’s largest independent operator of pathology laboratories
by: Fengxiang Xie, et al.
Published: (2019-11-01)

Testing positive for Human Papillomavirus (HPV) at primary HPV cervical screening: A qualitative exploration of women’s information needs and preferences for communication of results
by: Sophie Mulcahy Symmons, et al.
Published: (2021-12-01)

Outcomes of prior cervical cytology and HR-HPV testing in women subsequently diagnosed with CIN1, CIN2/3, and invasive cervical cancer: a 4-year routine clinical experience after implementation of systematic training and quality control programs
by: Dongman Zhao, et al.
Published: (2020-08-01)

Evaluation of the SureX HPV genotyping test for the detection of high-risk HPV in cervical cancer screening
by: Baojun Wei, et al.
Published: (2020-11-01)

Risk of cervical lesions in high-risk HPV positive women with normal cytology: a retrospective single-center study in China
by: Zhiling Wang, et al.
Published: (2020-05-01)

Validation of intra- and inter-laboratory reproducibility of the Xpert HPV assay according to the international guidelines for cervical cancer screening
by: Ajmal Akbari, et al.
Published: (2018-10-01)

Cervical cancer screening using HPV tests on self-samples: attitudes and preferences of women participating in the VALHUDES study
by: Hélène De Pauw, et al.
Published: (2021-08-01)

Cervical acid phosphatase detection: A guide to abnormal cells in cytology smear screening for cervical cancer
by: Deb Prabal, et al.
Published: (2008-01-01)

HPV-associated cervical diseases: screening, methods of examination, principles of treatment
by: Vera N Prilepskaya
Published: (2019-06-01)

The epidemiologic and economic impact of a quadrivalent human papillomavirus vaccine in Thailand.
by: Wichai Termrungruanglert, et al.
Published: (2021-01-01)

Personalized Cotesting Policies for Cervical Cancer Screening: A POMDP Approach
by: Malek Ebadi, et al.
Published: (2021-03-01)

Utility of Human Papillomavirus Testing for Cervical Cancer Screening in Korea
by: Mee-seon Kim, et al.
Published: (2020-03-01)

Triaging HPV-positive, cytology-negative cervical cancer screening results with extended HPV genotyping and p16INK4a immunostaining in China
by: Fangbin Song, et al.
Published: (2021-04-01)

The 2001 Bethesda System
by: Bergeron Christine
Published: (2003-01-01)

Urine collection in cervical cancer screening – analytical comparison of two HPV DNA assays
by: Mette Tranberg, et al.
Published: (2020-12-01)

Budget impact analysis of cervical cancer screening in Portugal: comparison of cytology and primary HPV screening strategies
by: Angela Pista, et al.
Published: (2019-02-01)

International algorithms for the management of patients with uterine cervical dysplasia
by: Yu E Dobrokhotova, et al.
Published: (2018-10-01)

The prevalence and role of human papillomavirus genotypes in primary cervical screening in the northeast of China
by: Wang Shizhuo, et al.
Published: (2012-05-01)

Screening for cervical cancer: new alternatives and research
by: Lörincz Attila T
Published: (2003-01-01)

Cost-effectiveness and accuracy of cervical cancer screening with a high-risk HPV genotyping assay vs a nongenotyping assay in China: an observational cohort study
by: Binhua Dong, et al.
Published: (2020-08-01)

Comparative accuracy of Pap smear and HPV screening in Ubon Ratchathani in Thailand
by: Suleeporn Sangrajrang, et al.
Published: (2017-06-01)

Investigation of Disparities in Cervical Cancer Prevention in the United States: HPV Vaccination and PAP Screening in 18-30 Year Old Women
by: Newransky, Chrisann
Published: (2013)

HPV risk factors and screening among Malawian women
by: Esber, Allahna Lauren
Published: (2016)

Methodologies of Primary HPV Testing Currently Applied for Cervical Cancer Screening
by: Andreas C. Chrysostomou, et al.
Published: (2020-11-01)

CYTOLOGICAL SCREENING OF THE CERVICAL CANCER: FROM THE TRADITIONAL PAP-TEST TO COMPUTER TECHNOLOGIES
by: G. N. Мinkinа
Published: (2017-06-01)

Understanding the role of oncogenic human papillomavirus (HPV) status on adherence behaviors among women with abnormal cervical cytology
by: Catriona Buick, et al.
Published: (2021-01-01)

Randomised trial of HPV self-sampling among non-attenders in the Slovenian cervical screening programme ZORA: comparing three different screening approaches
by: Ivanus Urska, et al.
Published: (2018-09-01)

A population-based study of cervical cytology findings and human papillomavirus infection in a suburban area of Thailand
by: Phoolcharoen, Natacha, et al.
Published: (2017)

Impact of human papillomavirus (HPV) self-collection on subsequent cervical cancer screening completion among under-screened US women: MyBodyMyTest-3 protocol for a randomized controlled trial
by: Lisa P. Spees, et al.
Published: (2019-12-01)

Cervical cancer screening using the Cervista high-risk human papillomavirus test: opportunistic screening of a hospital-based population in Fujian province, China
by: Ruan GY, et al.
Published: (2018-09-01)

Evaluating the performance of three different cervical cancer screening modalities in a large prospective population-based cohort
by: Fangbin Song, et al.
Published: (2020-11-01)